PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED

NATerminatedINTERVENTIONAL
Enrollment

541

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

July 28, 2022

Study Completion Date

August 30, 2022

Conditions
Covid-19 VaccineVaccine Hesitancy
Interventions
OTHER

Covid-19 vaccine education materials

videos and flyers containing Covid-19 vaccine educational information

Trial Locations (7)

19107

Thomas Jefferson University Hospital, Philadelphia

19114

Jefferson Torresdale Hospital, Philadelphia

19148

Jefferson Methodist Hospital, Philadelphia

27708

Duke University Hospital, Durham

94110

San Francisco General Hospital Emergency Department, San Francisco

94143

University of California, San Francisco - Parnassus, San Francisco

98104

University of Washington-Harborview Emergency Department, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

University of Washington

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER

NCT05142332 - PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED | Biotech Hunter | Biotech Hunter